- Home
- PED vs ALGS Comparison
PED vs ALGS Comparison
Compare PED & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- ALGS
- Stock Information
- Founded
- PED N/A
- ALGS 2018
- Country
- PED United States
- ALGS United States
- Employees
- PED N/A
- ALGS N/A
- Industry
- PED Oil & Gas Production
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- ALGS Health Care
- Exchange
- PED Nasdaq
- ALGS Nasdaq
- Market Cap
- PED 49.1M
- ALGS 56.7M
- IPO Year
- PED N/A
- ALGS 2020
- Fundamental
- Price
- PED $0.48
- ALGS $9.86
- Analyst Decision
- PED Strong Buy
- ALGS Strong Buy
- Analyst Count
- PED 1
- ALGS 2
- Target Price
- PED $1.50
- ALGS $60.00
- AVG Volume (30 Days)
- PED 164.5K
- ALGS 90.2K
- Earning Date
- PED 11-17-2025
- ALGS 11-06-2025
- Dividend Yield
- PED N/A
- ALGS N/A
- EPS Growth
- PED 156.43
- ALGS N/A
- EPS
- PED 0.11
- ALGS N/A
- Revenue
- PED $33,244,999.00
- ALGS $2,646,000.00
- Revenue This Year
- PED N/A
- ALGS N/A
- Revenue Next Year
- PED $17.41
- ALGS N/A
- P/E Ratio
- PED $4.40
- ALGS N/A
- Revenue Growth
- PED N/A
- ALGS N/A
- 52 Week Low
- PED $0.45
- ALGS $3.76
- 52 Week High
- PED $1.00
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- PED 29.29
- ALGS 63.81
- Support Level
- PED $0.45
- ALGS $5.81
- Resistance Level
- PED $0.54
- ALGS $7.00
- Average True Range (ATR)
- PED 0.03
- ALGS 0.79
- MACD
- PED -0.01
- ALGS 0.40
- Stochastic Oscillator
- PED 12.21
- ALGS 92.81
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.